The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children

European Journal of Pediatrics

Volumn 168, Issue 9, 2009, Pages 1043-1048

  Guran, Tulay ^a   Turan, Serap ^a   Bereket, Abdullah ^a   Akcay, Teoman ^a   Unluguzel, Goksenin ^a   Bas, Firdevs ^b   Gunoz, Hulya ^b   Saka, Nurcin ^b   Bundak, Ruveyde ^b   Darendeliler, Feyza ^b   Isguven, Pinar ^c   Yildiz, Metin ^c   Adal, Erdal ^d   Sarikaya, Sevil ^d   Baygin, Leyla Akin ^d   Memioglu, Nihal ^e   Onal, Hasan ^f   Ercan, Oya ^f   Haklar, Goncagul ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Bakirkoy Maternity and Children's Hospital   (Turkey)

^e SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hypothalamic obesity; Insulin; Leptin; Resistin; Soluble insulin receptor

Indexed keywords

INSULIN; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR, HUMAN; RESISTIN; RETN PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BLOOD; BODY MASS; CHILD; CRANIOPHARYNGIOMA; DYSGERMINOMA; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS TUMOR; MALE; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ASTROCYTOMA; BODY MASS INDEX; CHILD; CRANIOPHARYNGIOMA; DYSGERMINOMA; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HOMEOSTASIS; HUMANS; HYPOTHALAMIC NEOPLASMS; HYPOTHALAMUS; INSULIN; LEPTIN; MALE; OBESITY; RECEPTORS, LEPTIN; RESISTIN;

EID: 75549090651     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-008-0876-x     Document Type: Article

References (30)

1. Ainsworth BE, Haskell WL, Leon AS (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71-80 (Pubitemid 23027685)
2. American Diabetes Association (2000) Type 2 diabetes in children (consensus statement). Diabetes Care 23(3):381-389
3. Anderlová K, Kremen J, Dolezalová R (2006) The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res 55(3):277-283
4. Banerjee RR, Rangwala SM, Shapiro JS (2004) Regulation of fasted blood glucose by resistin. Science 303:1195-1198 (Pubitemid 38233585)
5. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719-809 (Pubitemid 9236601)
6. Chanchay S, Tungtrongchitr R, Harnroongroj T (2006) Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int J Vitam Nutr Res 76(3):125-131 (Pubitemid 44661297)
7. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):1240-1243 (Pubitemid 30240471)
8. Housová J, Anderlová K, Křížová J (2004) Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90:1366-1370
9. Igaki N, Tanaka M, Goto T (2005) Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin. Intern Med 44(8):832-837 (Pubitemid 41263829)
10. Iqbal N, Seshadri P, Stern L (2005) Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 9(3):161-165 (Pubitemid 40975765)
11. Lammert A, Kiess W, Bottner A (2001) Soluble leptin receptor presents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283:982-988 (Pubitemid 32924677)
12. Lehrke M, Reilly MP, Millington SC (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:e45
13. Lustig RH (2006) Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab 2(8):447-458
14. Lustig RH, Hinds PS, Ringwald-Smith K (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88(6):2586-2592 (Pubitemid 36724428)
15. Lustig RH, Rose SR, Burghen GA (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162-168 (Pubitemid 30180530)
16. McTernan PG, McTernan CL, Chetty R (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407
17. Muse ED, Lam TK, Scherer PE, Rossetti L (2007) Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117(6):1670-1678 (Pubitemid 46871351)
18. Müller HL, Müller-Stöver S, Gebhardt U (2006) Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 19(Suppl 1):423-429
19. Pastucha D, Malincíková J, Hyjánek J (2007) Obesity and insulin resistance in childhood. Cent Eur J Public Health 15(3):103-105
20. Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, Kibirige MS, Price DA, Shalet SM, Wales JK, Ross RJ, Clayton PE, Northern Paediatric Endocrine Group, UK (2002) Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction. J Pediatr Endocrinol Metab 15(7):963-971
21. Proto C, Romualdi D, Cento RM (2007) Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader Willi and the Down syndromes. Metabolism 56(8):1076-1080 (Pubitemid 47021171)
22. Rangwala SM, Rich AS, Rhoades B (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53(8):1937-1941 (Pubitemid 38970738)
23. Reinehr T, Kratzsch J, Kiess W, Andler W (2005) Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int J Obes (Lond) 29(10):1230-1235 (Pubitemid 43080302)
24. Rose SR, Schreiber RE, Kearney NS (2004) Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17(1):55-66 (Pubitemid 38931012)
25. Roth C, Wilken B, Hanefeld F (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138(1):89-91 (Pubitemid 28078816)
26. Rutter MM, Rose SR (2007) Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19(4):480-487 (Pubitemid 47075631)
27. Shaikh MG, Grundy R, Kirk J (2008) Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. Eur J Endocrinol, Sep 26 (in press)
28. Srinivasan S, Ogle GD, Garnett SP (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81-86 (Pubitemid 38183863)
29. Tiosano D, Eisentein I, Militianu D (2003) 11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity. J Clin Endocrinol Metab 88(1):379-384 (Pubitemid 36115192)
30. Zou CC, Liang L, Hong F (2007) Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Indian Pediatr 44(4):275-279 (Pubitemid 46663594)